The main objective of the “Societal Benefit of Markerless Stereotactic Body Radiotherapy: a Statistical Support based on Quantitative Imaging” (SmartQi) project is to improve the efficiency of advanced radiotherapeutic techniques and to increase patient access to state-of-the-art radiation therapy. SmartQi allows a collaboration between various research domains, such as radiotherapy, radiology, biostatistics and health economics.
The role of I-CHER in this project is to promote value-based healthcare and evaluate its broader impact on hospitals and society.
Within this project, a combination of innovative methodologies, patient-level simulation models and time-driven activity-based costing, is used to conduct comprehensive cost-benefit analyses of radiotherapy innovations. The goal is to ensure that resources are allocated to interventions that deliver the greatest value to patients, ultimately improving the quality, accessibility, and cost-effectiveness of radiation oncology services.
Furthermore, a socio-economic evaluation will be executed, accounting for the costs and benefits for health service providers as well as an analysis where the societal perspective is adopted.
Contact persons of the project: Eva Kimpe & Sara-Lise Busschaert